Expression of Sterol Regulatory Element-Binding Proteins in epicardial adipose tissue in patients with coronary artery disease and diabetes mellitus: preliminary study.

Objectives: Sterol regulatory element-binding proteins (SREBP) genes are crucial in lipid biosynthesis and cardiovascular homeostasis. Their expression in epicardial adipose tissue (EAT) and their influence in the development of coronary artery disease (CAD) and type-2 diabetes mellitus remain to be...

Descripción completa

Detalles Bibliográficos
Autores: Pérez-Belmonte, Luis M, Moreno-Santos, Inmaculada, Cabrera-Bueno, Fernando, Sánchez-Espín, Gemma, Castellano, Daniel, Such, Miguel, Crespo-Leiro, María G, Carrasco-Chinchilla, Fernando, Alonso-Pulpón, Luis, López-Garrido, Miguel, Ruiz-Salas, Amalio, Becerra-Muñoz, Víctor M, Gómez-Doblas, Juan J, de Teresa-Galván, Eduardo, Jiménez-Navarro, Manuel
Tipo de recurso: artículo
Fecha de publicación:2017
País:España
Institución:Instituto de Salud Carlos III (ISCIII)
Repositorio:Repisalud
Idioma:inglés
OAI Identifier:oai:repisalud.isciii.es:20.500.12105/17292
Acceso en línea:http://hdl.handle.net/20.500.12105/17292
Access Level:acceso abierto
Palabra clave:Sterol regulatory element-binding proteins (SREBP)
coronary artery disease
epicardial adipose tissue
type-2 diabetes mellitus.
Adipose Tissue
Aged
Coronary Artery Disease
Diabetes Mellitus, Type 2
Female
Humans
Lipid Metabolism
Male
Middle Aged
Pericardium
Risk Factors
Sterol Regulatory Element Binding Protein 1
Sterol Regulatory Element Binding Protein 2
Sterols
Descripción
Sumario:Objectives: Sterol regulatory element-binding proteins (SREBP) genes are crucial in lipid biosynthesis and cardiovascular homeostasis. Their expression in epicardial adipose tissue (EAT) and their influence in the development of coronary artery disease (CAD) and type-2 diabetes mellitus remain to be determined. The aim of our study was to evaluate the expression of SREBP genes in EAT in patients with CAD according to diabetes status and its association with clinical and biochemical data. Methods: SREBP-1 and SREBP-2 mRNA expression levels were measured in EAT from 49 patients with CAD (26 with diabetes) and 23 controls without CAD or diabetes. Results: Both SREBPs mRNA expression were significantly higher in patients with CAD and diabetes (p